Evidence map›Paper›PMID 32664792›Full record

ArticleJournal of neurotrauma2020

Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.

Sharon D Yeatts, Reneé H Martin, William Meurer, Robert Silbergleit, Gaylan L Rockswold, William G Barsan, Frederick K Korley, David W Wright, Byron J Gajewski

Registry-linked trialAbstract read
In one paragraph

Article in Journal of neurotrauma, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02407028 (Hyperbaric Oxygen Brain Injury Treatment), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02407028 phase2recruitingnot on this map

Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial

TypeinterventionalSponsorGaylan RockswoldRan2018 to 2029Enrolled200ConditionsTraumatic Brain InjuryArmsHyperbaric oxygen (1.5 ATA, no NBH), Hyperbaric oxygen (2.0 ATA, no NBH), Hyperbaric oxygen (2.5 ATA, no NBH), Hyperbaric oxygen (1.5 ATA + NBH), Hyperbaric oxygen (2.0 ATA + NBH)
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. The times are changing: A primer on novel clinical trial designs and endpoints in critical care research.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharon D YeattsDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Reneé H MartinDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
William MeurerDepartment of Emergency Medicine, University of Michigan. Ann Arbor, Michigan, USA.
Robert SilbergleitDepartment of Emergency Medicine, University of Michigan. Ann Arbor, Michigan, USA.
Gaylan L RockswoldDepartment of Neurosurgery, University of Minnesota, Hennepin County Medical Center, Minneapolis, Minnesota, USA.
William G BarsanDepartment of Emergency Medicine, University of Michigan. Ann Arbor, Michigan, USA.
Frederick K KorleyDepartment of Emergency Medicine, University of Michigan. Ann Arbor, Michigan, USA.
David W WrightDepartment of Emergency Medicine, Emory University, Atlanta, Georgia, USA.
Byron J GajewskiDepartment of Biostatistics & Data Science, University of Kansas Medical Center. Kansas City, Kansas, USA.

Funding

Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)U01NS099046 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ramon Diaz-Arrastia, Lori Shutter · 2018 to 2026
$35.7M
ProTECT IIIU01NS062778 · NINDS · EMORY UNIVERSITY · PI WRIGHT, DAVID W · 2009 to 2013
$26.4M
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCCU01NS095926 · NINDS · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI Byron J. Gajewski, Frederick Kofi Korley · 2017 to 2026
$12.3M
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating CenterU24NS100655 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI VALERIE L DURKALSKI, Sharon Dziuba Yeatts · 2017 to 2026
$4.4M
Hyperbaric Oxygen BrainInjury Treatment (HOBIT) Trial-SDMC Supplement FITBIRU01NS095814 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARTIN, RENEE HEBERT · 2017 to 2022
$2.3M
NINDS NIH HHS U01 NS062778NINDS NIH HHS U01 NS095814NINDS NIH HHS U01 NS095926NINDS NIH HHS U01 NS099046NINDS NIH HHS U24 NS100655
6 · The paper itself

Abstract

The Glasgow Outcome Scale-Extended (GOS-E), an ordinal scale measuring global outcome, is used commonly as the primary outcome measure in clinical trials of traumatic brain injury. Analysis is often based on a dichotomization and thus has inherent statistical limitations, including loss of information related to the collapse of adjacent categories. A fixed dichotomization defines favorable outcome consistently for all subjects, whereas a sliding dichotomy tailors the definition of favorable outcome according to baseline prognosis/severity. Literature indicates that the sliding dichotomy is more statistically efficient than the fixed dichotomy; however, the sliding dichotomy still collapses categories and therefore discards information. We propose an alternative, a sliding scoring system for the GOS-E, intended to address the limitations of the sliding dichotomy. The score is assigned based on the number of levels between the achieved score and the favorable cut-point. The proposed scoring system reflects the magnitude of change, where change is defined according to each subject's baseline prognosis. Because the score is approximately continuous, statistical methods can rely on the normal distribution, both for analysis and study design. Two examples show the corresponding potential for improved power. A sliding score approach allows for quantification of the magnitude of change while still accounting for prognosis. Scientific advantages include increased power and an intuitive interpretation.

Indexed as

Brain Injuries, TraumaticGlasgow Outcome ScaleOutcome Assessment, Health CareClinical Trials as TopicHumansGlasgow Outcome Scale-Extendedsliding scorestatistical analysis

Identifiers

PMID32664792
PMCPMC7757546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.